Vanderbilt University — Nashville, Tennessee

Public research footprint of Vanderbilt University, compiled from the ClinicalTrials.gov public registry.

3,665

Registered studies

1,084

Active

527

Recruiting now

2,011

Completed

492

Stopped or withdrawn

Most-studied conditions

Acute Respiratory Distress Syndrome (ARDS) · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Metastatic Bladder Large Cell Neuroendocrine Carcinoma · Recurrent Malignant Solid Neoplasm

Recently updated registry entries

NCT04924075 — Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… (Recruiting)
NCT07232069 — PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis (Recruiting)
NCT03306082 — Image-guided Cochlear Implant Programming (IGCIP) (Enrolling By Invitation)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Vanderbilt University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.